Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Drugs And New Concerns: Gaining Insight Through Pharmacovigilance Of Direct Acting Anti-Viral's In Chronic HCV Patients

NCT04664894 is registered in ClinicalTrials.gov with Getz Pharma as lead sponsor.

NCT NCT04664894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Drugs And New Concerns: Gaining Insight Through Pharmacovigilance Of Direct Acting Anti-Viral's In Chronic HCV Patients
Lead sponsor
Getz Pharma
Phase
Observational
Overall status
Completed
Start date
May 15, 2018
Completion date
May 30, 2019
Enrollment
511 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues